Design and Synthesis of New 6-Nitro and 6-Amino-3,3a,4,5-Tetrahydro-2<i>H</i>-Benzo[<i>g</i>]indazole Derivatives: Antiproliferative and Antibacterial Activity
Viviana Cuartas,
María del Pilar Crespo,
Eva-María Priego,
Leentje Persoons,
Dirk Daelemans,
María-José Camarasa,
Braulio Insuasty,
María-Jesús Pérez-Pérez
Affiliations
Viviana Cuartas
Grupo de Investigación de Compuestos Heterocíclicos, Departamento de Química, Universidad del Valle, A. A., Cali 25360, Colombia
María del Pilar Crespo
Grupo de Biotecnología e Infecciones Bacterianas, Departamento de Microbiología, Universidad del Valle, Cali 760043, Colombia
Eva-María Priego
Instituto de Química Médica (IQM, CSIC), Juan de la Cierva 3, 28006 Madrid, Spain
Leentje Persoons
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
Dirk Daelemans
KU Leuven Department of Microbiology, Immunology and Transplantation, Laboratory of Virology and Chemotherapy, Rega Institute for Medical Research, KU Leuven, Herestraat 49, 3000 Leuven, Belgium
María-José Camarasa
Instituto de Química Médica (IQM, CSIC), Juan de la Cierva 3, 28006 Madrid, Spain
Braulio Insuasty
Grupo de Investigación de Compuestos Heterocíclicos, Departamento de Química, Universidad del Valle, A. A., Cali 25360, Colombia
María-Jesús Pérez-Pérez
Instituto de Química Médica (IQM, CSIC), Juan de la Cierva 3, 28006 Madrid, Spain
New substituted benzo[g]indazoles functionalized with a 6-nitro and 6-amino groups have been synthesized by the reaction of benzylidene tetralones with hydrazine in acetic acid. The resulting conformationally-constrained compounds were evaluated for their antiproliferative activity against selected cancer cell lines. The nitro-based indazoles 11a, 11b, 12a and 12b have shown IC50 values between 5−15 μM against the lung carcinoma cell line NCI-H460. Moreover, the nitro compounds were tested for antibacterial activity where compounds 12a and 13b have shown MIC values of 250 and 62.5 μg/mL against N. gonorrhoeae with no hemolytic activity in human red blood cells (RBC).